(Journal of Leukocyte Biology. 2001;69:675-683.)
© 2001
by Society for Leukocyte Biology
Regulation of L-selectin expression by a dominant negative Ikaros protein
Indu Christopherson,
Marie Piechoki,
Guo Liu,
Stuart Ratner and
Anne Galy
Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan
Correspondence: Anne Galy, Ph.D., Karmanos Cancer Institute, Wayne State University, 110 E. Warren Ave., Detroit, MI 48201. E-mail: galya{at}karmanos.org
 |
ABSTRACT
|
|---|
Ikaros family members play critical roles in hematopoietic development,
yet molecules regulated by Ikaros proteins remain incompletely
characterized. To determine the requirements for functional Ikaros
proteins, we overexpressed Ik7, a dominant negative Ikaros protein, in
human cell lines and hematopoietic progenitor cells. Ik7 is known to
block the normal function of other Ikaros family members in human and
mouse cells. Retroviral-mediated overexpression of Ik7 affected two
distinct, migratory properties of the CEM T-cell line. Ik7
down-regulated L-selectin cell-surface expression, an
effect not a result of increased shedding but of a decrease in
L-selectin mRNA levels. Ik7 also reduced the spontaneous
migration of CEM T cells in 3-D collagen gels. A reduction in
L-selectin, cell-surface expression was also induced by Ik7
in CD34+ hematopoietic progenitor cells. In contrast, the
Reh B cell line showed an up-regulation of L-selectin,
cell-surface levels when expressing Ik7. For the first time, this study
defines an effect of Ikaros proteins in the control of
migration-related properties and shows that intact Ikaros proteins are
important in a cell type-specific manner for the normal regulation of
L-selectin expression.
Key Words: human progenitor cells dendritic cells hematopoietic development
 |
INTRODUCTION
|
|---|
Members of the Ikaros family of proteins play an important role in
hematopoiesis as shown in animals with an Ikaros null
mutation or in model systems where the normal function of Ikaros
proteins is abolished by dominant negative proteins
[1
2
3
4
]. Alterations in the normal function and
respective levels of Ikaros family members reduce lymphopoiesis
severely and can cause leukemia and lymphoma, underscoring the
importance of these proteins in the control of cell-cycle and
chromosome stability of lymphocytes [1
, 5
,
6
]. Initially described as a lymphoid-specific
transcription factor with binding sites in T-cell-associated genes, it
has become clear that Ikaros proteins play an important role in cells
other than lymphocytes. Ikaros is found in early hematopoietic
progenitor cells [7
, 8
], and mice
overexpressing a dominant negative Ikaros protein exhibit stem-cell
defects constitutively [9
]. Ikaros proteins also control
the development of dendritic cell populations [3
,
4
]. The role played by Ikaros proteins remains
incompletely characterized. Ikaros proteins localize to heterochromatin
regions [7
, 10
] where they participate in
higher-order chromatin complexes and control gene expression through
various mechanisms [11
, 12
]. Defining which
molecules and genes are affected by Ikaros proteins is an important
step in understanding the role of these proteins in hematopoietic
cells. The dominant negative protein, Ik7, is the product of
gene-targeting deletion of exons 3 and 4 in the wild-type Ikaros locus
(Fig. 1A
), causing a strong reduction in the DNA-binding ability of the
hetero-complexes formed between Ik7 and other members of the Ikaros
family of proteins through their C-terminal, zinc-finger modules
[13
]. Members of the Ikaros family of proteins include
Ikaros, Aiolos, Helios, Daedalus, and the newly described Eos and
Pegasus [14
]. When overexpressed in human hematopoietic
progenitor cells, Ik7 causes a reduction in flt3 receptor and
interferes with the production of dendritic cells in response to
specific signals [4
]. To further understand the
molecular targets of Ik7, we analyzed the expression of molecules known
to be important for hematopoietic cells. Large-scale analysis of human
progenitor cells was precluded by the number of cells available for
analysis; therefore, cell lines were tested. L-selectin is
a cell-surface molecule found on leukocytes and hematopoietic
progenitor cells, which recognize ligands present on endothelial cells
in lymph nodes and inflammatory sites. L-selectin is
critically important for cellular trafficking [15
].
Herein, we demonstrate that Ik7 affects the expression of
L-selectin in a T-cell line and in progenitor cells. Ik7
also affected migration of T cells in collagen gels. Overall, our
results show for the first time that Ikaros proteins control some
aspects of leukocyte migration.

View larger version (36K):
[in this window]
[in a new window]
|
Figure 1. (A) Organization of the Ikaros gene. Gray boxes represent exons, and
open vertical rectangles represent zinc-finger modules. Arrows indicate
the localization of primers. The predicted size of products obtained
with these primers by RT-PCR is indicated on the right. (B) Retroviral
vectors used in the study.
|
|
 |
MATERIALS AND METHODS
|
|---|
Retroviral vector construction and virus production
Murine Ik7 (a kind gift of Dr. Katia Georgopoulos, Harvard
Medical School, Boston, MA) was cloned into the Moloney-based
bicistronic, retroviral vector LZRS-IRES-EGFP [16
,
17
] (a kind gift of Dr. Hergen Spits, Netherlands Cancer
Institute, Amsterdam, The Netherlands) as described [4
].
Briefly, the plasmid pCDM8Mik1/2 containing Ik7 was digested with
EcoRI and cloned into LZRS-IRES-EGFP using standard
techniques [18
]. The constructs LZRS-Ik7-IRES-EGFP (13.6
kb) and control LZRS-IRES-EGFP (12.4 kb; Fig. 1B
) were transformed into
stbl2-competent cells (Gibco BRL, Grand Island, NY), and the
LZRS-Ik7-IRES-EGFP plasmid DNA was sequenced, confirming proper
orientation and correct in-frame sequence (Wayne State University
Macromolecular Core Facility, Detroit, MI). Plasmids were transfected
into Phoenix-amphotropic packaging cells (a kind gift of Dr. G. Nolan,
Stanford University, Stanford, CA), using Superfect, according to the
manufacturers instructions (Qiagen, Valencia, CA). Transfectants were
selected in puromycin (1 µg/ml) for 1 week to select for high-titer,
virus-producing cells. Virus-containing supernatant was collected from
confluent monolayers cultured for 48 h in R10 medium (RPMI-1640;
Gibco-BRL), L-glutamine (2 mM), penicillin-streptomycin (100 U/ml and
100 µg/ml, respectively), 2-mercaptoethanol
(2x10-5 M), and 10% cosmic calf serum
(Hyclone, Logan, UT), filtered (0.45 µm) and cryopreseved at
-80°C. The absence of helper activity and virus titers was
determined by measuring enhanced green fluorescent protein
(EGFP)-expressing cells after infection of the human colon
carcinoma cell line HCT116 (American Type Culture Collection, Manassas,
VA). Virus batches of high titer (>5x105
UEGFP/ml) were used.
Preparation of variant cell lines
T-lymphoblastic CCRF-CEM (CEM) cells (4x105 cells;
a kind gift of Dr. Al-Katib, Wayne State University) were infected in
one well of a 24-well plate with 0.5 ml undiluted, virus-containing
supernatant by spin-infection [19
] at 3000 g
for 3 h at room temperature in the presence of 20 mM Hepes and 5
µg/ml protamine sulfate. Immediately after infection, 0.5 ml fresh
R10 medium was added before returning cells to 37°C incubation. The
next day, cells were washed to remove virus. Live cells expressing EGFP
were sorted on a VANTAGE sorter and subsequently cultured as described
above. In some experiments, cells were treated for 24 h at 37°C,
5% CO2 with various amounts of phorbol myristate acetate
(Sigma Chemical Co., St. Louis, MO).
The Reh acute, B-leukemic cell line was obtained as a generous gift of
Dr. A. Al-Katib (Wayne State University), and cells were cultured and
transduced as described with CEM cells.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA was isolated using RNA isolator (Genosys, The
Woodlands, TX), and reverse transcription of approximately 1 µg RNA
was done at 37°C for 1 h in MMLV reaction buffer
supplemented with 400 U Moloney murine leukemia virus RT in the
presence of 160 U RNAsin-RNAse inhibitor, 100 nmoles dATP, dCTP, dTTP,
and dGTP (Promega, Madison, WI), and 0.5 nmole random hexamers
(Genosys) in 100 µl vol. Usually, 1020 µl cDNA was amplified in
PCR by 2 U Ampli-Taq DNA polymerase (Perkin Elmer, Foster City, CA) in
the presence of 200 µM each dNTP, 2.5 mM MgCl2, and 1
µM (beta 2-microglobulin) or 0.25 µM (Ikaros) primers diluted in
Taq reaction buffer in 100 µl vol using a personal thermocycler
(Biometra, Tampa, FL) for 30 cycles (1 min at 94°C, 2 min at 55°C,
and 1 min at 72°C). Primers used for the amplification of normal and
mutant Ikaros isoforms cDNA are shown by arrows in Figure 1A hex2F (5'
CCCCTGTAAGCGATACTCCAGATG 3') and hEx7R (5' GATGGCTTGGTCCATCACGTGGGA
3')and generate multiple transcripts in human cells ranging from 900
bp to 500 bp [4
, 20
]. Primers used to
detect beta 2-microglobulin mRNA were ß2MF (5' GAATTGCTATGTGTCTCGGT
3') and ß2MR (5' CATCTTCAAACCTCCATGATG 3'), generating a 257-bp
product. The PCR products were stained with ethidium bromide or
transferred to nylon membrane (MSI, Westboro, MA) for Southern
analysis. A 32P-labeled, Ikaros-1 cDNA probe was obtained
by amplification of human thymus cDNA with hex2F and hEx7R primers and
labeled with the Prime-a-gene labeling system (Promega). Blot
hybridization and high-stringency washes were done according to
standard procedures [18
], and radioactivity was detected
on the Storm imager (Molecular Dynamics, Sunnyvale, CA).
Detection of cell-surface antigens by flow cytometry
Antibody dilution and staining buffer consisted of
phosphate-buffered saline (PBS) with 0.2% bovine serum albumin (BSA)
and 0.02% sodium azide. Cells were first incubated with 1 mg/ml human
gamma globulin for 10 min on ice to reduce nonspecific, Fc-receptor
binding, prior to adding antibodies for 30 min and washing cells twice
in staining buffer. The antibodies used in the staining are listed in
Table 1
. For indirect staining, cells were incubated with
phycoerythrin-conjugated, goat anti-mouse antibodies (Chemicon,
Temecula, CA) or with streptavidin-phycoerythrin (Becton Dickinson, San
Jose, CA). After two washes, cells were resuspended in buffer with
phosphatidylinositol (PI) and analyzed on the FacScan instrument.
Results were expressed as percentage of live cells staining above
control (control stainings with irrelevant antibodies always gave
background <2%) or as mean fluorescence intensity (mfi), as
determined with the PC lysis software (Becton Dickinson).
Detection of L-selectin shedding by enzyme-linked
immunosorbent assay (ELISA)
CEM T cells were cultured in R10 at the concentration of 1 x 106 cells per ml per well of a 48-well plate (Costar,
Cambridge, MA) for 24 h at 37°C, 5% CO2 with
varying amounts of phorbol 12-myristate 13-acetate (PMA). Cell-free
supernatant was collected and tested in duplicate in a specific ELISA
assay with a detection threshold of about 0.9 ng/ml, according to the
manufacturers instructions (R&D Systems, Minneapolis, MN).
Northern blot analysis
Total RNA was isolated as described above, and 5 µg RNA per
lane was separated by electrophoresis before being stained with
ethidium bromide to record RNA integrity. Gels were vaccum-blotted onto
nylon membranes, subsequently hybridized with 32P-labeled
human L-selectin probe. The probe consisted of a 1.2-kb DNA
fragment obtained by EcoRI digestion of
PCR2.1-L-selectin plasmid (a kind gift of Dr. T. Watanabe,
University of Tokyo, Japan). The signal ratio between the 2.6-kb
transcript and rRNA 28S was calculated with the Image Quant software
(Molecular Dynamics).
Bone marrow (BM) progenitor-cell preparation and transduction
Human BM was isolated from rib fragments removed from patients
undergoing thoracic surgery, according to institutional guidelines.
Mononuclear cells (MNC) were prepared by centrifugation through Ficoll
(Pharmacia, Piscataway, NJ) and cryopreserved with 10% dimethyl
sulfoxide (DMSO) in liquid nitrogen. For preparation of
CD34+ hematopoietic progenitor cells, BM-MNC were thawed in
the presence of DNAse (100 U/ml) and heparin (10 U/ml; Sigma),
centrifuged through Ficoll to collect viable cells at gradient
interface. Cells were washed once, incubated with excess human
gamma-globulins (1 mg/ml Gamimune; Miles, Eckhart, IN) to reduce
nonspecific, Fc-receptor binding prior to incubation with monoclonal
antibodies (mAbs) against CD34 (Qbend10; Immunotech Inc., Westbrook,
ME) for 30 min on ice. After two washes, goat anti-mouse,
colloidal-paramagnetic beads (Miltenyi Biotec GmBH, Sunnyvale, CA) were
added, and CD34+ cells were obtained after passage through
a magnetic field. Purity of the cell population was routinely >85%.
The CD34+ cells were incubated at 37°C in a humidified
atmosphere with 5% CO2 in R10 medium supplemented with
human recombinant c-kit ligand (50 ng/ml), interleukin (IL)-6 (25
ng/ml), and IL-3 (12.5 ng/ml; kind gifts of Dr. Hill, Systemix Inc.,
Palo Alto, CA). After 48 h, cells were infected by spin-infection
on 24-well plates coated with 8 µg/cm2 fibronectin
fragments (Retronectin; Takara Biomedicals, Shiga, Japan). After
centrifugation, 0.5 ml medium with cytokines was added per well, and
cells were returned to 37°C. The next day, cells were washed and
transferred to another plate with fresh medium and cytokines. Two days
after infection, cells were stained with phycoerythrin-conjugated,
anti-CD34mAbs (Caltag, Burlingame, CA) and PI (5 µg/ml) to isolate
live (excluding PI), CD34+ cells expressing, or not, EGFP
by cell sorting on a VANTAGE instrument (Becton Dickinson). To examine
L-selectin expression, cells were stained simultaneously
with sulforhodamine-conjugated, anti-CD34 mAbs (a kind gift of Dr. B.
Hill, Systemix) and phycoerythrin (PE)-conjugated mAbs to CD62-L.
Collagen gel-migration assay
An acid solution of rat-tail collagen was mixed with ice-cold,
concentrated RPMI 1640 medium to yield a 1.2 mg/ml collagen-monomer
solution of physiological osmolality. This was pipeted into 22-mm
diameter culture wells and allowed to polymerize at 37°C into gels
approximately 3-mm thick. Cells were suspended in 1,2-dimethoxyethane
(DME) containing 0.05%, lipid-free BSA (Sigma) and added to the wells
at a density of 2 x 106 cells per cm2 gel
surface. After a migration period of 16 h at 37°C, gels were
fixed by addition of 33% paraformaldehyde to a final concentration of
3%. Leading-front distance was measured as the maximum depth at which
3 cells were simultaneously in focus in a 400x field, as determined
by a fine-focus adjustment, which was calibrated in µm travel.
Triplicate measurements were made, each counting cells in five fields
per gel. Fields were chosen randomly within a 10-mm circle whose center
coincided with the center of the gel.
 |
RESULTS
|
|---|
Retroviral-mediated expression of Ik7 in the CEM T-cell line
We introduced the mutant Ik7 dominant negative protein into CEM T
cells by retroviral-mediated gene transfer to study the requirements
for functional Ikaros proteins in these cells. Parental CEM T cells
expressed high levels of endogenous Ikaros mRNAs as seen by RT-PCR
analysis with primers spanning exons 2 and 7 of the Ikaros
gene (Figs. 1A
and 2
). In particular, CEM cells
expressed the DNA-binding, high molecular-weight isoform Ik1
[13
] but did not seem to overexpress low
molecular-weight, dominant negative isoforms in agreement with other
studies [21
]. For these reasons, CEM cells could be
affected by the enforced expression of a dominant negative Ikaros
protein potentially and thus, were used. The bi-cistronic, retroviral
vector LZRS-Ik7-IRES-EGFP contains cDNA sequences encoding the highly
conserved, murine Ik7 protein and EGFP (Fig. 1B)
[4
] and
was used to transduce CEM T cells, generating the CEM-Ik7-EGFP cell
line. A control cell line, CEM-control-EGFP, was prepared at the same
time by transduction of the same parental CEM-cell stock with the
LZRS-IRES-EGFP vector encoding only EGFP (Fig. 1B)
. Cells expressing
the transgene were detected on the basis of EGFP expression and
purified twice by flow cytometry to generate homogeneous cell lines.
RT-PCR analysis of the resulting cell lines confirmed that CEM-Ik7-EGFP
but not the parental CEM or CEM-control-EGFP cells expressed the 467-bp
product corresponding to Ik7 (Fig. 2)
. Results also showed that CEM-Ik7-EGFP expressed multiple, endogenous
Ikaros mRNA transcripts with patterns similar to CEM-control-EGFP or
parental CEM cells, suggesting that Ik7 did not affect endogenous
Ikaros gene expression severely.

View larger version (45K):
[in this window]
[in a new window]
|
Figure 2. Ik7 expression in CEM T-cell variants by RT-PCR. Results show
ethidium-bromide staining of gels after amplification of the various
isoforms of Ikaros and beta 2-microglobulin cDNAs in CEM parent and
variant cells. Amplification of water was used as a negative control.
|
|
Ik7 down-regulates L-selectin surface levels and mRNA
in CEM T cells
Flow cytometric analysis of mutant CEM cells was performed to
determine if Ik7 induced changes in the expression of various
cell-surface molecules. We found that L-selectin, which is
normally expressed on all CEM cells at high levels, was down-regulated
consistently by Ik7, as noted by reduced mfi of CD62-L staining
(Fig. 3
). The analysis of seven independent experiments showed
consistently a partial down-regulation in the mfi in CEM-Ik7-EGFP cells
compared with CEM-control-EGFP cells (Table 2
). When directly conjugated, anti-L-selectin antibodies
were used, a less-intense signal was obtained causing the shift of a
greater proportion of cells below detection when expressing Ik7.
Overall, in these seven experiments, the median inhibition of
L-selectin expression based on staining intensity was 40%,
ranging from 31% to 57%. The inhibition was statistically significant
(p=0.007 by paired t-test analysis). These
results suggest that fewer molecules of L-selectin were on
CEM-Ik7-EGFP cell surface compared with CEM-control-EGFP cells.

View larger version (21K):
[in this window]
[in a new window]
|
Figure 3. Flow cytometric analysis of L-selectin expression in CEM
variant cells. The top histogram represents the background staining
obtained with irrelevant antibodies on CEM-control-EGFP cells
(gray-filled histogram) and CEM-Ik7-EGFP (thick-lined histogram). The
bottom histogram represents an overlay of CD62-L staining on these
cells, and the mfi of each population is indicated.
|
|
One mechanism for the down-regulation of L-selectin in T
lymphocytes is through shedding the molecule. In T cells,
L-selectin shedding can be induced by treatment with PMA
[22
]. Treatment of CEM-control-EGFP cells with
increasing concentrations of PMA resulted in a dose-dependent reduction
of cell-surface, L-selectin mfi by flow cytometry
(Fig. 4A
) and an increase in the shedding of L-selectin in
culture medium as detected by ELISA (Fig. 4B)
. Culturing CEM-Ik7-EGFP
cells with increasing concentrations of PMA caused further
down-regulation of L-selectin on their cell surface (Fig. 4A)
but only a modest augmentation in L-selectin shedding
(Fig. 4B)
. Noticeably, baseline shedding was lower in CEM-Ik7-EGFP
cells than in CEM-control-EGFP cells, excluding the possibility that
L-selectin shedding was spontaneously dysregulated by
mechanisms, independent of protein kinase C activation [23].
Altogether, these results suggest that L-selectin shedding
is not the mechanism involved in Ik7-induced down-regulation of
L-selectin on the surface of CEM cells.

View larger version (26K):
[in this window]
[in a new window]
|
Figure 4. Regulation of L-selectin expression in CEM cells after PMA
treatment. Variant CEM cells were treated with increasing
concentrations of PMA for 24 h. Representative results of two
independent experiments. (A) L-selectin, cell-surface
expression measured by flow cytometry using anti-CD62-L mAbs on live
cells excluding PI and expressed as mfi. (B) L-selectin
shed in culture medium after 24 h as measured by ELISA.
|
|
Northern blot analysis showed that Ik7 down-regulated
L-selectin mRNA levels in CEM cells (Fig. 5
). CEM cells, like other lymphocytes, expressed two transcripts, a
major species of 2.6 kb and a minor transcript at 1.7 kb, corresponding
to the use of an alternative poly(A) signal sequence
[24
]. Variant CEM-Ik7-EGFP cells expressed about half
the level of the major L-selectin transcript than
CEM-control-EGFP cells (Fig. 5)
. These results are consistent with the
observed, partial down-regulation of L-selectin on the cell
surface and with the detection of low amounts of shedding in medium in
cells expressing Ik7. Thus, Ik7 reduces L-selectin protein
and mRNA levels in CEM T cells. These results define a requirement for
functional Ikaros proteins in the control of L-selectin
levels.

View larger version (38K):
[in this window]
[in a new window]
|
Figure 5. Northern blot analysis of L-selectin mRNA expression in CEM
variant cells. The top blot was hybridized with an
L-selectin-specific probe and shows two transcripts. The
bottom blot shows the detection of 28S and 18S ribosomal RNAs by
ethidium-bromide stain on a digitally converted image. Numbers indicate
the ratio of signal for the 2.6-kb transcript to 28S RNA.
|
|
Ik7 down-regulates L-selectin on hematopoietic
progenitor cells
L-selectin is an important cell-surface receptor that
directs traffic and homing of several types of leukocytes (reviewed in
[15
]). In particular, L-selectin is found on
CD34+ hematopoietic progenitor cells [25
].
We examined if L-selectin levels of CD34+ cells
were affected by Ik7. Previously, we demonstrated that
CD34+ cells could be transduced with Ik7, and these studies
delineated a requirement for functional Ikaros proteins in the
expression of the flt-3 receptor and in differentiation of progenitor
cells into dendritic cells [4
]. As shown earlier, we
infected CD34+ cells after a short culture in the presence
of IL-3, c-kit ligand, and IL-6cytokines known to promote retroviral
gene transfer and maintain primitive, clonogenic-progenitor cells
[26
]. Two days after infection of CD34+
cells, 1050% of cells in culture expressed EGFP. As partial
differentiation into CD34- cells was induced by this
culture step, we re-isolated CD34+ progenitor cells and
purified transduced and nontransduced CD34+ cells by
multi-color, flow cytometry sorting (Fig. 6A
). These sorted cell populations were used in RT-PCR to
demonstrate the specific expression of Ik7 mRNA transcript in
Ik7-transduced CD34+ EGFP+ (Fig. 6B
, lane 2)
but the lack of it in cells transduced by the control virus (lane 1)
and in nontransduced cells (lanes 3 and 4). Although CD34+
cells expressed various endogenous Ikaros transcripts, we observed that
the ratio of high-molecular Ik1 isoform to other isoforms was lower
than in CEM T cells. Such difference in Ikaros-isoform expression
between progenitor cells and T cells has already been shown in murine
cells [7
]. We determined L-selectin
expression on transduced CD34+ cells two days after viral
infection, using multi-color, flow cytometric analysis. Results of two
independent experiments showed that Ik7 caused a 50% reduction in
numbers of CD34+ cells with detectable
L-selectin (Fig. 6C
, from 14% to 6%), and on those cells,
there was a reduction in mfi, indicating that fewer molecules of
L-selectin were present per cell (Fig. 6C)
. Noticeably,
control cells (left dot plot) that were transduced with the control
virus (EGFP+ population) had lower levels of
L-selectin (14% of EGFP+ cells) than control,
nontransduced cells (37% in the EGFP- cell population),
suggesting that retroviral manipulation may by itself decrease
L-selectin levels partially in CD34+ cells. In
spite of this, comparing control-transduced (EGFP+ cells,
left plot) and Ik7-transduced cells (EGFP+ cells, right
plot) showed that Ik7 decreased L-selectin specifically in
CD34+ cells. Thus, Ikaros proteins are important for
expression of normal levels of L-selectin in hematopoietic
progenitor cells and in T cells.

View larger version (61K):
[in this window]
[in a new window]
|
Figure 6. Expression of Ik7 in human CD34+ progenitor cells and
regulation of L-selectin levels. (A) CD34+
cells were infected with viruses encoding Ik7-EGFP or EGFP only; two
days after infection, cells were stained with anti-CD34 mAbs to isolate
progenitor cells transduced or not by flow cytometry. The two dot-plot
panels on the right show cells obtained by sorting Ik7-infected but not
transduced CD34+ EGFP- cells and Ik7-infected, transduced
CD34+ EGFP+ cells. Numbers indicate the
percentage of cells in the respective quadrants. (B) Southern blotting
analysis of Ikaros mRNA in sorted CD34+ cells after RT-PCR. (C)
L-selectin expression on CD34+ progenitor cells
was measured two days after infection, using sulforhodamine-conjugated,
anti-CD34-mAbs and phycoerythin-conjugated, anti-CD62-L mAbs, and PI
dot plots were obtained after electronic gating on live cells
(PI-) and CD34+ cells and represent the
correlated expression of CD62-L and EGFP. Numbers in the upper-left
quadrant indicate the percentage of EGFP- (nontransduced) cells that
express CD62-L. Numbers in the upper-right quadrant indicate the
proportion of EGFP+ (transduced) cells that express CD62-L
and the mfi of this population.
|
|
Ik7 up-regulates L-selectin in the Reh B cell line
To determine if the effects of Ik7 were similar in various cell
types, we analyzed cell lines expressing L-selectin. One
such line, the Reh acute lymphocytic, leukemia cell line contains
2040% cells expressing CD62-L. Reh cells were infected with control
or Ik7 viruses resulting in bulk cell lines containing 3070%
EGFP+ cells. These bulk cell lines were not purified to
homogeneity but were stained with L-selectin antibodies to
determine expression. Results from two experiments showed that by
electronic gating on EGFP+ cells, Ik7 up-regulated the
number of cells expressing L-selectin (Fig. 7
). Thus, unlike in CEM T cells, Ik7 augments
L-selectin in Reh cells, showing that the control of
L-selectin expression by Ikaros proteins may be
cell-specific.

View larger version (24K):
[in this window]
[in a new window]
|
Figure 7. L-selectin expression in Reh B cells by flow cytometry. One
representative experiment out of two. Histogram represents
L-selectin expression in cells transduced with control
(left)- or Ik7 (right)-containing vectors. Analysis was done on the
EGFP+ cell population selected by electronic gating.
|
|
Ik7 reduces the migration of CEM T cells in 3-D collagen gels
The density of L-selectin at the cell surface of
leukocytes determines, in part, their ability to enter structures by
binding to endothelial venules. The ability to migrate further into
tissues is regulated by molecules other than L-selectin
(reviewed in refs 15
, 27
, 28
).
An assessment of L-selectin-independent migratory
properties was made by measuring the spontaneous migration of CEM T
cells in 3-D collagen lattices, which mimics some of the biochemical
and biophysical characteristics of migration through interstitial
tissues. Spontaneously locomoting cells, such as CEM T cells, are able
to penetrate into the collagen lattice by random movements in the
absence of chemoattractants, using cell-matrix or biophysical
interactions [29
]. CEM cell lines were deposited onto
preformed collagen lattices, and migration distance into the gel was
measured after a fixed period of time (16 h). Results showed that
CEM-Ik7-EGFP cells migrated significantly less far into collagen gels
than CEM-control-EGFP cells or than other control CEM cells that were
transfected stably with the pTracer plasmid encoding the EGFP protein
(Fig. 8
). It has been determined that the migration of
locomoting T cells spontaneously in 3-D collagen gels does not involve
ß1, ß2, ß3,
v,
4,
6, or CD11a integrins based on
blocking studies and analysis of subcellular localization of these
molecules during this process [28
, 30
].
However, migration in 3-D collagen gels may involve VLA-2 because
antibodies to CD49b (
2) inhibit the spontaneous migration of some
populations of CD4+ T cells in this system
[30
]. In two separate experiments, we did not detect
changes in the levels of CD49b expression in CEM-Ik7-EGFP cells
compared with CEM-control-EGFP cells using immunoflow cytometry (Table 2)
.

View larger version (38K):
[in this window]
[in a new window]
|
Figure 8. Migration of CEM variants in collagen gel. One representative
experiment out of three. Results indicate the average ±
SD of triplicate measurement of leading-edge migration of
transduced CEM cells expressing Ik7 or not and of a control CEM line
transfected with a plasmid encoding EGFP.
|
|
In spite of their unlikely involvement in the system, we measured the
expression of CD29 ß1 integrin and CD18 ß2 integrin, which were
expressed at high levels on CEM cells but not changed consistently nor
significantly by Ik7 expression (for both, n=3,
p>0.05 in paired t-tests; Table 2
). CD11a
(unpublished results), CD11b, and CD11c (Table 2)
were expressed at low
levels that were not affected by Ik7. We conclude that the diminished
motility in 3-D collagen gels reflected, most likely, changes of
receptor affinity or other motor protein function. We also conclude
that the perturbations in migratory-related properties of CEM cells
were not part of a general misregulation of cell-surface protein
expression.
 |
DISCUSSION
|
|---|
Prior studies in murine and human models have implicated Ikaros
proteins in the control of cell-cycle, growth-factor receptor
expression and cellular differentiation [4
,
9
, 31
]. Our study implicates for the first
time a role of Ikaros proteins in the control of migratory properties.
L-selectin is a member of the selectin family of adhesion
molecules that is found on most leukocytes, mediating the early step of
extravasation by facilitating leukocyte-rolling onto endothelium
[15
, 27
]. Herein, we demonstrate for the
first time that Ikaros proteins are involved in the control of normal
levels of L-selectin expression, because perturbations are
induced by expression of a dominant negative Ikaros protein, Ik7. The
down-regulation of L-selectin mRNA by Ik7 in CEM T cells
suggests the possibility that Ikaros proteins may control
L-selectin transcription. The transcription initiation
region of L-selectin is not defined fully and may lay
further than 10-kb upstream of exon 2 where the translation-initiation
site is found [24
]. However, a putative,
L-selectin promoter region was identified in a region of
about 900 bp flanking the 5' end of exon 2 and could be transactivated
by human T-cell lymphotropic virus 1 (HTLV-1) Tax protein
[32
]. In this region, we detected two elements with
Ikaros core motif sequences (GGGAA) [13
], and throughout
the gene, seven other motifs were found. Thus, it is possible that
Ikaros proteins may act as direct activators of L-selectin
transcription. In models of transcription using reporter genes
containing consensus Ikaros binding sites, full-length Ikaros proteins
such as Ik1 activate transcription, whereas truncated forms such as Ik7
interfere with transcription [13
]. Ik7, which lacks
DNA-binding, N-terminal zinc fingers (Fig. 1A) but contains intact,
C-terminal zinc fingers, forms heterodimers with other Ikaros proteins,
thus reducing the DNA binding of these complexes on these reporter
constructs. Thus, it is conceivable that Ik7 could reduce
L-selectin transcription by interfering with normal binding
of Ikaros proteins on regulatory sequences in the
L-selectin gene. Formal proof of this mechanism will have
to be obtained in further studies. Ikaros proteins can also regulate
transcription by associating with heterochromatin as shown initially in
B cells [10
], and in that context, one mechanism of
suppression is by recruitment of histone deacetylase complexes to
specific promoters [12
]. Opposite effects of Ik7 were
observed on different cells. Ik7 down-regulated L-selectin
levels in CEM T cells and in hematopoietic progenitor cells but
up-regulated L-selectin expression in Reh B cells. These
observations suggest the possibility that Ikaros proteins may control
L-selectin expression in a cell type-specific manner and
perhaps through distinct mechanisms. In transcription models Ikaros
proteins, including IK7, bind to heterologous DNA-binding domains of
other proteins and can function as repressors of transcription
[12
]. The amplitude of suppression was promoter- and
cell type-specific and also varied among Ikaros proteins. Thus, Ik7
could function as a repressor of L-selectin in some cells
but not others. Ikaros proteins are important in the control of T-cell
receptor-mediated activation [31
]. Although CEM T cells
do not express T-cell receptors on their surface, the possibility that
Ikaros proteins control L-selectin expression, not through
a direct effect on gene transcription but indirectly through other
aspects of cell activation, must also be considered. This underlies the
complex role that Ikaros proteins play in gene regulation among cells
of the hematopoietic system.
The biological relevance of our observations remains to be addressed
formally, but our results suggest a possible relevance in the control
of migration. We show that Ik7 causes a partial but not complete
reduction in L-selectin expression. The analysis of
cell-surface protein levels and mRNA levels suggests approximately a
50% reduction. Although modest, this reduction could nevertheless have
biological consequences because mice hemizygous for an
L-selectin null mutation and therefore expressing half as
much L-selectin as normal mice exhibit perturbations in
migration with a 5070% decrease in short-term entry of cells into
peripheral lymphoid tissues [33
]. To explore migratory
properties further and evaluate aspects of leukocyte extravasation that
are independent of L-selectin, we examined migration in
collagen gels and analyzed the expression of some integrin chains on
CEM T cells. We observed that Ik7 decreased migration in collagen gels
but had no consistent effect on the expression of the integrin chains
examined. Nevertheless, the reduced migration in collagen lattices
coupled to decreased L-selectin levels suggests that a
migratory syndrome defect might be occurring in cells with perturbed
Ikaros function, predicting a reduced localization in hematopoietic
organs. Normal Ikaros protein function is presumably perturbed in some
leukemias such as T-ALL and blast-crisis chronic myelogenous leukemias
(CML), because these cells over-abundantly express dominant negative
isoforms of Ikaros and exhibit some mutations in the Ikaros gene
[34
, 35
]. CD34+ cells from
patients with CML have decreased L-selectin expression
[36
]. Our results suggest the possibility that Ikaros
dominant negative proteins could affect L-selectin
expression and migration in these leukemic cells and may be relevant to
their high rate of circulation. Further studies are warranted.
 |
ACKNOWLEDGEMENTS
|
|---|
This work was supported by the American Cancer Society grant
RPG-98-183-01 and by a grant from Systemix Inc. The authors are
grateful to Drs. Georgopoulos, Spits, Hill, and Al-Katib for gifts of
reagents and cell lines and in particular to Dr. Watanabe for his
generous contribution of human L-selectin plasmid. The authors thank
the Harper Operation Room staff for help in procurement of bone marrow
and also acknowledge the excellent technical support provided by the
Flow Cytometry Core Facility of the Karmanos Cancer Institute.
Received June 2, 2000;
revised January 16, 2001;
accepted January 17, 2001.
 |
REFERENCES
|
|---|
-
Georgopoulos, K., Bigby, M., Wang, J. H., Molnar, A., Wu, P., Winandy, S., Sharpe, A. (1994) The Ikaros gene is required for the development of all lymphoid lineages Cell 79,143-156[Medline]
-
Wang, J. H., Nichogiannopoulou, A., Wu, L., Sun, L., Sharpe, A., Bigby, M., Georgopoulos, K. (1996) Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation Immunity 5,537-549[Medline]
-
Wu, L., Nichogiannopoulou, A., Shortman, K., Georgopoulos, K. (1997) Cell-autonomous defect in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage Immunity 7,483-492[Medline]
-
Galy, A., Christopherson, I., Ferlazzo, G., Liu, G., Spits, H., Georgopoulos, K. (2000) Distinct signals control the hematopoiesis of lymphoid-related dendritic cells Blood 95,128-137[Abstract/Free Full Text]
-
Wang, J. H., Avitahl, N., Cariappa, A., Friedrich, C., Keda, T., Renold, A., Andrikopoulos, K., Liang, L., Pilai, S., Morgan, B., Georgopoulos, K. (1998) Aiolos regulates B cell activation and maturation to effector state Immunity 9,543-553[Medline]
-
Winandy, S., Wu, P., Georgopoulos, K. (1995) A dominant negative mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma Cell 83,289-299[Medline]
-
Klug, C., Morrison, S., Masek, M., Hahm, K., Smale, S., Weissman, I. (1998) Hematopoietic stem cells and lymphoid progenitors express different Ikaros isoforms, and Ikaros is localized to heterochromatin in immature lymphocytes Proc. Natl. Acad. Sci. USA 95,657-662[Abstract/Free Full Text]
-
Galy, A., Morel, F., Hill, B., Chen, B. P. (1998) Hematopoietic progenitor cells of lymphocytes and dendritic cells J. Immunother. 21,132-141
-
Nichogiannopoulou, A., Trevisan, M., Neben, S., Friedrich, C., Georgopoulos, K. (1999) Defects in hemopoietic stem cell activity in Ikaros mutant mice J. Exp. Med. 190,1201-1214[Abstract/Free Full Text]
-
Brown, K., Guest, S., Smale, S., Hahm, K., Merkenschlager, M., Fisher, A. (1997) Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin Cell 91,845-854[Medline]
-
Kim, J., Sif, S., Jones, B., Jackson, A., Koipally, J., Heller, E., Winandy, S., Viel, A., Sawyer, A., Ikeda, T., Kingston, R., Georgopoulos, K. (1999) Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes Immunity 10,345-355[Medline]
-
Koipally, J., Renold, A., Kim, J., Georgopoulos, K. (1999) Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes EMBO J 18,3090-3100[Medline]
-
Sun, L., Liu, A., Georgopoulos, K. (1996) Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development EMBO J 15,5358-5369[Medline]
-
Perdomo, J., Holmes, M., Chong, B., Crossley, M. (2000) Eos and Pegasus, two members of the Ikaros family of proteins with distinct DNA binding activities J. Biol. Chem. 275,38347-38354[Abstract/Free Full Text]
-
Stamenkovic, I. (1995) The L-selectin adhesion system Curr. Opin. Hematol. 2,68-75[Medline]
-
Kinsella, T., Nolan, G. (1996) Episomal vectors rapidly and stably produce high-titer recombinant retrovirus Hum. Gene Ther. 7,1405-1413[Medline]
-
Heemskerk, M., Blom, B., Nolan, G., Stegmann, A. P., Bakker, A., Weijer, K., Res, P., Spits, H. (1997) Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3 J. Exp. Med. 186,1597-1602[Abstract/Free Full Text]
-
Ausubel, F., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., Struhl, K. (1995) Current Protocols in Molecular Biology Janssen, K. eds. John Wiley & Sons New York.
-
Bahnson, A. B., Dunigan, J. T., Baysal, B. E., Mohney, T., Atchison, R. W., Nimgaonkar, M. T., Ball, E. D., Barranger, J. A. (1995) Centrifugal enhancement of retroviral-mediated gene transfer J. Virol. Meth. 54,131-143[Medline]
-
Molnar, A., Wu, P., Largespada, D. A., Vortkamp, A., Scherer, S., Copeland, N. G., Jenkins, N. A., Bruns, G., Georgopoulos, K. (1996) The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA binding proteins, highly conserved in human and mouse J. Immunol. 156,585-592[Abstract]
-
Hosokawa, Y., Maeda, Y., Seto, M. (2000) Low frequency of expression of dominant-negative Ikaros isoforms in human leukemia and lymphoma cell lines Leuk. Res. 24,263-264[Medline]
-
Kaldjian, E. P., Stoolman, L. M. (1995) Regulation of L-selectin mRNA in Jurkat cells. Opposing influences of calcium- and protein kinase C-dependent signaling pathways J. Immunol. 154,4351-4362[Abstract]
-
Stoddart, J. J., Jasuja, R., Sikorski, M., von Andrian, U., Mier, J. (1996) Protease-resistant L-selectin mutants. Down-modulation by cross-linking but not cellular activation J. Immunol. 157,5653-5659[Abstract]
-
Ord, D. C., Ernst, T., Zhou, L. J., Rambaldi, A., Spertini, O., Griffin, J., Tedder, T. F. (1990) Structure of the gene encoding the human leukocyte adhesion molecule-1 (TQ1, leu-8) of lymphocytes and neutrophils J. Biol. Chem. 14,7760-7767
-
Lund-Johansen, F., Terstappen, L. W. (1993) Differential surface expression of cell adhesion molecules during granulocyte maturation J. Leukoc. Biol. 54,47-55[Abstract]
-
Conneally, E., Bardy, P., Eaves, C. J., Thomas, T., Chappel, S., Shpall, E. J., Humphries, R. K. (1996) Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer Blood 87,456-464[Abstract/Free Full Text]
-
Tedder, T., Steeber, D., Chen, A., Engel, P. (1995) The selectins: vascular adhesion molecules FASEB J 9,866-873[Abstract]
-
Friedl, P., Brocker, E. B. (2000) The biology of cell locomotion within three-dimensional extracellular matrix Cell Mol. Life Sci. 57,41-64[Medline]
-
Friedl, P., Entschladen, F., Conrad, C., Niggemann, B., Zanker, K. (1998) CD4+ T lymphocytes migrating in three-dimensional collagen lattices lack focal adhesions and utilize b1 integrin-independent strategies for polarization, interaction with collagen fibers and locomotion Eur. J. Immunol. 28,2331-2343[Medline]
-
Friedl, P., Noble, P., Zanker, K. (1995) T lymphocyte locomotion in a three-dimensional collagen matrix J. Immunol. 154,4973-4985[Abstract]
-
Winandy, S., Wu, L., Wang, J., Georgopoulos, K. (1999) Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros J. Exp. Med. 190,1039-1048[Abstract/Free Full Text]
-
Tatewaki, M., Yamaguchi, K., Matsuoka, M., Ishii, T., Miyasaka, M., Mori, S., Takatsuki, K., Watanabe, T. (1995) Constitutive overexpression of the L-selectin gene in fresh leukemic cells of adult T-cell leukemia that can be transactivated by human T-cell lymphotropic virus type 1 Tax Blood 86,3109-3117[Abstract/Free Full Text]
-
Tang, M., Steeber, D., Zhang, X., Tedder, T. (1998) Intrinsic differences in L-selectin expression levels affect T and B lymphocyte subset-specific recirculation pathways J. Immunol. 160,5113-5121[Abstract/Free Full Text]
-
Sun, L., Crotty, M., Sensel, M., Sather, H., Navara, C., Nachman, J., Steinherz, P., Gaynon, P., Seibel, N., Mao, C., Vassilev, A., Reaman, G., Uckun, F. (1999) Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia Clin. Cancer Res. 5,2112-2120[Abstract/Free Full Text]
-
Nakayama, H., Ishimaru, F., Avitahl, N., Sezaki, N., Fujii, N., Nakase, K., Ninomiya, Y., Harashima, A., Minowada, J., Tsuchiyama, J., Imajoh, K., Tsubota, T., Fukuda, S., Sezaki, T., Kojima, K., Hara, M., Takimoto, H., Yorimitsu, S., Takahashi, I., Miyata, A., Taniguchi, S., Tokunaga, Y., Gondo, H., Niho, Y., Harada, M., et al (1999) Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia Cancer Res 59,3931-3934[Abstract/Free Full Text]
-
Kawaishi, K., Kimura, A., Katoh, O., Sasaki, A., Oguma, N., Ihara, A., Satow, Y. (1996) Decreased L-selectin expression in CD34-positive cells from patients with chronic myelocytic leukemia Br. J. Hematol. 93,367-374[Medline]
This article has been cited by other articles:

|
 |

|
 |
 
S. Ezzat, X. Zhu, S. Loeper, S. Fischer, and S. L. Asa
Tumor-Derived Ikaros 6 Acetylates the Bcl-XL Promoter to Up-Regulate a Survival Signal in Pituitary Cells
Mol. Endocrinol.,
November 1, 2006;
20(11):
2976 - 2986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Movassagh, D. Laderach, and A. Galy
Proteins of the Ikaros family control dendritic cell maturation required to induce optimal Th1 T cell differentiation
Int. Immunol.,
June 1, 2004;
16(6):
867 - 875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Perry, H. Wang, L. J. Pierce, A. M. Yang, S. Tsai, and G. J. Spangrude
L-selectin defines a bone marrow analog to the thymic early T-lineage progenitor
Blood,
April 15, 2004;
103(8):
2990 - 2996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ezzat, S. Yu, and S. L. Asa
Ikaros Isoforms in Human Pituitary Tumors: Distinct Localization, Histone Acetylation, and Activation of the 5' Fibroblast Growth Factor Receptor-4 Promoter
Am. J. Pathol.,
September 1, 2003;
163(3):
1177 - 1184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fruehauf, J. Topaly, M. Schad, P. Paschka, H. Gschaidmeier, W. J. Zeller, A. Hochhaus, and A. D. Ho
Imatinib restores expression of CD62L in BCR-ABL-positive cells
J. Leukoc. Biol.,
May 1, 2003;
73(5):
600 - 603.
[Abstract]
[Full Text]
[PDF]
|
 |
|